Editorial for "Comparison between diffusion weighted MRI and 123 I-MIBG uptake in primary high risk neuroblastoma"
- PMID: 33426752
- DOI: 10.1002/jmri.27507
Editorial for "Comparison between diffusion weighted MRI and 123 I-MIBG uptake in primary high risk neuroblastoma"
References
-
- Swift CC, Eklund MJ, Kraveka JM, Alazraki AL. Updates in diagnosis, management and treatment of neuroblastoma. Radiographics. 2018;38(2):566-80.
-
- Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging neuroblastic tumors. Consensus report from the INRG project. Radiology. 2011;261(1):243-57.
-
- Sharp SE, Gelfand MJ, Shulkin BL. Pediatrics: diagnosis of neuroblastoma Semin Nucl Med. 2011;41(5):345-353.
-
- Demir S, Altinkaya N, Kocer NE, Erbay A, Oguzkurt P. Variations in apparent diffusion coefficient values following chemotherapy in pediatric neuroblastoma. Diagn Interv Radiol. 2015;21:184-8.
-
- Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, et al. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma. Ann Nucl Med. 2018;32(5):348-62.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical